Marjorie Taylor Greene
Marjorie Taylor Greene (R-GA) bought $1K-$15K of $ADBE (Adobe Inc. - Common Stock) on Sep 11, 2025, part of 11 transactions in this filing.
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
5 flagsRep. Marjorie Taylor Greene bought $1,001 - $15,000 in $CRWD on 2025-09-11, 40 days before the Foreign Robocall Elimination Act (S2666) was enacted, a bill that could increase demand for advanced analytics and fraud detection.
Rep. Marjorie Taylor Greene bought $1,001 - $15,000 in $GS on 2025-09-11, 54 days before the Merchant Banking Modernization Act (HR5291) was enacted, which extends the holding period for merchant banking investments by financial holding companies.
Rep. Marjorie Taylor Greene bought $1,001 - $15,000 in $MS on 2025-09-11, 54 days before the Merchant Banking Modernization Act (HR5291) was enacted, which extends the holding period for merchant banking investments by financial holding companies.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Government Securities | US TREASURY BILL 09/03/2025(Government Securities) | $100K-$250K | — | — | — | Sep 11, 2025 |
| BUY | $ADBE | Adobe Inc. - Common Stock | $1K-$15K | $350.55 | — | — | Sep 11, 2025 |
| BUY | $GOOG | Alphabet Inc. - Class C Capital Stock | $1K-$15K | $240.78 | — | — | Sep 11, 2025 |
| BUY | $AMGN | Amgen Inc. - Common Stock | $1K-$15K | $282.73 | — | — | Sep 11, 2025 |
| BUY | $ASML | ASML Holding N.V. - New York Registry Shares | $1K-$15K | $804.16 | — | — | Sep 11, 2025 |
| BUY | $CRWD | CrowdStrike Holdings, Inc. - Class A Common Stock | $1K-$15K | $433.38 | — | — | Sep 11, 2025 |
| BUY | $DLR | Digital Realty Trust, Inc. Common Stock | $1K-$15K | $174.67 | — | — | Sep 11, 2025 |
| BUY | $DUK | Duke Energy Corporation | $1K-$15K | $122.11 | — | — | Sep 11, 2025 |
| BUY | $GS | Goldman Sachs Group, Inc. | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $IBIT | iShares Bitcoin Trust ETF - iShares Bitcoin Trust ETF | $1K-$15K | — | — | — | Sep 11, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Billionaires Income Tax Act
The Billionaires Income Tax Act (HR 5427) is an early-stage House bill proposing annual mark-to-market taxation of unrealized capital gains for billionaires. Real market data shows alternative asset managers Blackstone and Carlyle trading at $122.51 and $48.94 respectively after 7-day declines of 0.71% and 1.28%, with Carlyle down 6.94% over the past week. BlackRock at $1056.19 bucked the trend with a 7-day gain of 1.07%, reflecting its status as a potential beneficiary of capital rotation from illiquid to liquid assets. The bill remains stuck in committee with 32 cosponsors and no hearings — low probability of passage in the 119th Congress, but the market is already pricing structural risk.
End Rent Fixing Act of 2025
The End Rent Fixing Act of 2025 (HR6124) is an early-stage bill targeting algorithmic rental pricing coordination. It has 30 cosponsors and a Senate companion (S3207), indicating coordinated Democratic support. The bill authorizes no funding — it is a prohibition. REITs with heavy residential exposure face potential operating model disruption, while self-storage, industrial, retail, office, and data center REITs are either unaffected or only minimally exposed. The market has not priced this risk into residential REITs yet, as PSAs -5.38% 7-day drop is more likely due to other factors than this bill at current stage.
Lowering Drug Costs for American Families Act
The Lowering Drug Costs for American Families Act (HR6166) expands Medicare drug negotiation from 20 to 50 drugs and extends inflation rebates to commercial markets, targeting bearish revenue compression for major pharma ($MRK, $PFE, $LLY). Health insurers ($UNH, $CVS) face mixed effects — lower drug costs offset by new out-of-pocket caps. The bill is in early committee stage, giving markets time to price in the structural shift.
Biosimilar Red Tape Elimination Act
The Biosimilar Red Tape Elimination Act (HR5526) would remove FDA interchangeability study requirements, speeding market entry for $VTRS and $TEVA biosimilars. Market data shows $VTRS +11.55% and $TEVA +17.73% over 30 days, consistent with investors pricing in this regulatory catalyst. Innovators $AMGN (-2.11% 30-day), $JNJ (-5.95%), and $BIIB (+4.18%) face structural margin pressure as pharmacy-level substitution becomes automatic upon biosimilar approval.
AI-Related Job Impacts Clarity Act
The AI-Related Job Impacts Clarity Act (S3108) is an early-stage Senate bill requiring quarterly disclosures of AI-driven job changes. It imposes new compliance costs on major AI investors like Microsoft, Alphabet, Amazon, NVIDIA, and Meta without allocating any funding. Market impact is currently low given the bill's procedural status, but the transparency risk is real for AI-heavy companies.
ERISA Litigation Reform Act
HR6084, the ERISA Litigation Reform Act, has cleared the House Education & Workforce Committee on a party-line 19-13 vote and awaits floor action. The bill imposes a mandatory discovery stay during motions to dismiss and heightens pleading standards for ERISA fiduciary lawsuits, directly reducing legal costs and liability exposure for major financial institutions serving as retirement plan fiduciaries. BlackRock ($BLK), Charles Schwab ($SCHW), Morgan Stanley ($MS), JPMorgan Chase ($JPM), and Bank of America ($BAC) are the primary beneficiaries.
Water Cybersecurity Enhancement Act of 2025
HR5868 extends grant eligibility for water utility cybersecurity training through 2031, but it is an early-stage authorization bill with no new funding and remains referred to committee. Cybersecurity stocks have recently rallied on unrelated factors—$CRWD +19.03% and $PANW +17.62% over 30 days—but this bill is procedural noise, not a catalyst.
Foreign Robocall Elimination Act
The Foreign Robocall Elimination Act establishes an interagency taskforce on unlawful robocalls and mandates carriers to invest in cybersecurity and analytics infrastructure. No new funding is authorized, but the compliance-driven procurement cycle creates a structural demand uplift for leading cybersecurity platforms. $CRWD, $PANW, and $FTNT are best positioned, having already rallied +46% to +61% over 30 days in broad sector momentum.
Affordable Housing Bond Enhancement Act
The Affordable Housing Bond Enhancement Act (S1511) would expand mortgage revenue bond programs, lowering financing costs for first-time and moderate-income homebuyers. Entry-level homebuilders ($DHI, $LEN, $PHM, $KBH) are structurally positioned to benefit from increased buyer demand, while major bond underwriters ($BAC, $JPM, $WFC) could see modest fee increases from higher issuance volumes. The bill is early-stage (post-hearing in Senate Banking Committee, companion in House Ways and Means) with no appropriations — it changes tax code provisions, not direct spending.
Merchant Banking Modernization Act
The Merchant Banking Modernization Act (HR5291) extends the holding period for merchant banking investments from 10 to 15 years for financial holding companies. The bill is active and on the Union Calendar after passing committee with a 35-17 vote. This is a direct regulatory benefit for large banks engaged in private equity and merchant banking, particularly Goldman Sachs and Morgan Stanley, whose merchant banking divisions are core profit centers. The bill carries no direct federal spending — it is a regulatory change, not an appropriation.
Other Filings by Marjorie Taylor Greene
Free — no credit card
Get the next Greene trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.